On this page
Alphatec Holdings, Inc.
At 5% or more1
Filings1
Latest filing2025-12-17
Alphatec Holdings, Inc. has 1 Schedule 13D or 13G filing on record since 2025-12-17. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing identifies Alphatec Holdings, Inc. by CUSIP 02081G201 and gives its principal executive office as 1950 Camino Vida Roble, Carlsbad, CA 92008 (SCHEDULE 13D/A, 2025-12-17).
Swipe the table sideways to see every column.
BioCardia, Inc.
At 5% or more2
Filings3
Latest filing2025-09-24
BioCardia, Inc. has 3 Schedule 13D or 13G filings on record since 2025-08-13. 2 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names BioCardia, Inc., with its principal executive office as 320 Soquel Way, Sunnyvale, CA 94085 (SCHEDULE 13G, 2025-09-24).
Swipe the table sideways to see every column.
Blue Star Foods Corp.
At 5% or more1
Filings1
Latest filing2025-12-19
Blue Star Foods Corp. has 1 Schedule 13D or 13G filing on record since 2025-12-19. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names Blue Star Foods Corp., with its principal executive office as 3000 NW 109th Avenue, Miami, FL 33172 (SCHEDULE 13G, 2025-12-19).
Swipe the table sideways to see every column.
MaxsMaking Inc.
At 5% or more1
Filings1
Latest filing2025-12-04
MaxsMaking Inc. has 1 Schedule 13D or 13G filing on record since 2025-12-04. 1 holder's latest filing reports 5% or more of a shares. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names MaxsMaking Inc., with its principal executive office as Room 903, Building 2, Kangjian Business, No. 1288 Zhennan Road, Putuo District, Shanghai (SCHEDULE 13G, 2025-12-04).
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
Regen Biopharma, Inc.
At 5% or more1
Filings1
Latest filing2025-09-12
Regen Biopharma, Inc. has 1 Schedule 13D or 13G filing on record since 2025-09-12. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names Regen Biopharma, Inc., with its principal executive office as 4700 Spring Street, Suite 304, La Mesa, CA 91942 (SCHEDULE 13G, 2025-09-12).
Swipe the table sideways to see every column.
Robo.ai Inc.
At 5% or more1
Filings1
Latest filing2025-12-30
Robo.ai Inc. has 1 Schedule 13D or 13G filing on record since 2025-12-30. 1 holder's latest filing reports 5% or more of class b ordinary shares, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names Robo.ai Inc., with its principal executive office as Office 114-117, Floor 1, Building A1, Dubai Digital Park, Dubai Silicon Oasis, Dubai (SCHEDULE 13G, 2025-12-30).
Swipe the table sideways to see every column.
Sionix Corp
At 5% or more1
Filings1
Latest filing2025-12-16
Sionix Corp has 1 Schedule 13D or 13G filing on record since 2025-12-16. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names Sionix Corp, with its principal executive office as 2010 NORTH LOOP WEST, SUITE 110, HOUSTON, TX 77018 (SCHEDULE 13G/A, 2025-12-16).
Swipe the table sideways to see every column.
Tiziana Life Sciences Ltd
At 5% or more2
Filings3
Latest filing2025-12-10
Tiziana Life Sciences Ltd has 3 Schedule 13D or 13G filings on record since 2025-10-28. 2 holders' latest filing reports 5% or more of common. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing names Tiziana Life Sciences Ltd, with its principal executive office as 9th Floor, 107 Cheapside, LONDON, ENGLAND (SCHEDULE 13G/A, 2025-12-10).
Swipe the table sideways to see every column.
West Fraser Timber Co., Ltd
At 5% or more2
Filings3
Latest filing2026-11-09
West Fraser Timber Co., Ltd has 3 Schedule 13D or 13G filings on record since 2025-08-06. 2 holders' latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.
Swipe the table sideways to see every column.
Swipe the table sideways to see every column.
The latest filing identifies West Fraser Timber Co., Ltd by CUSIP 952845105 and gives its principal executive office as 885 WEST GEORGIA STREET, SUITE 1500, VANCOUVER (SCHEDULE 13D/A, 2026-11-09).
Item 3 of the Schedule 13D is hereby amended to add the following: The information set forth in Item 2 of this Amendment No. 6 is hereby incorporated by reference into this Item 3. The Restructuring involved the transfer of the entire (100%) equity interest in Banasino Investments S.a r.l. and did not involve any transfer of the Common Shares of the Issuer. No Common Shares were acquired or disposed of by any Reporting Person in connection with the Restructuring. The number of Common Shares directly held by Banasino Investments S.a r.l. (8,356,494) was not affected by the Restructuring.Banasino Investments S.a r.l., SCHEDULE 13D/A, 2026-11-09
Banasino Investments S.a r.l.
Item 4 of the Schedule 13D is hereby amended and restated as follows:
The Reporting Persons acquired the securities reported herein for investment purposes, subject to the following: The information in Items 2, 3 and 5 of this Amendment No. 6 and in Item 6 of the Schedule 13D is incorporated by reference into this Item 4.
The Reporting Persons expect to evaluate on an ongoing basis the Issuer's business and financial condition, results of operations and prospects and the Reporting Persons' respective interests in, and intentions with respect to, the Issuer and the Reporting Persons' respective investments in the securities of the Issuer; general economic and industry conditions; financial and stock market considerations, including the market price of securities of the Issuer and currency fluctuations; developments with respect to the business of the Reporting Persons; changes in law and government regulations; as well as other developments and other business or investment opportunities. Subject to and based upon that ongoing evaluation, the Reporting Persons may, at any time and from time to time, (i) determine to acquire additional securities of the Issuer, and the Reporting Persons reserve the right to acquire additional securities of the Issuer in the future, (ii) dispose of all or a portion of the securities of the Issuer owned by any of them, (iii) propose or undertake an extraordinary corporate transaction such as a tender offer or exchange offer for some or all of …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-11-09; the filing has the rest
Swipe the table sideways to see every column.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
All 5%+ stakes
